Metabolic Leaders' Forum
12 Mar 2012 - 14 Mar 2012 - San Francisco, CA, USA
The Metabolic Leaders’ Forum, 12-14 March in San Francisco is the meeting place for senior R&D executives from companies large and small tasked with de-risking drug development whilst driving innovation across the cardiometabolic field. Pinpoint the most promising opportunities in type 1 and 2 diabetes, obesity, diabetic complications and Dyslipidemia, and establish appropriate product profiles to efficiently and effectively demonstrate positive outcomes.
Don’t miss the opportunity to hear about approaches being taken by Roche, GSK, Sanofi, MedImmune, Amgen, BMS and others on “de-risking drug development whilst driving innovation in the new era of diabetes drug development”. For more information please visit www.phacilitate.co.uk/leaderswest